These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 39059381)

  • 1. Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5.
    Wang LT; Cooper AJR; Farrell B; Miura K; Diouf A; Müller-Sienerth N; Crosnier C; Purser L; Kirtley PJ; Maciuszek M; Barrett JR; McHugh K; Ogwang R; Tucker C; Li S; Doumbo S; Doumtabe D; Pyo CW; Skinner J; Nielsen CM; Silk SE; Kayentao K; Ongoiba A; Zhao M; Nguyen DC; Lee FE; Minassian AM; Geraghty DE; Traore B; Seder RA; Wilder BK; Crompton PD; Wright GJ; Long CA; Draper SJ; Higgins MK; Tan J
    Cell; 2024 Sep; 187(18):4981-4995.e14. PubMed ID: 39059381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies from malaria-exposed Malians generally interact additively or synergistically with human vaccine-induced RH5 antibodies.
    Willcox AC; Huber AS; Diouf A; Barrett JR; Silk SE; Pulido D; King LDW; Alanine DGW; Minassian AM; Diakite M; Draper SJ; Long CA; Miura K
    Cell Rep Med; 2021 Jul; 2(7):100326. PubMed ID: 34337556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional Comparison of Blood-Stage
    Illingworth JJ; Alanine DG; Brown R; Marshall JM; Bartlett HE; Silk SE; Labbé GM; Quinkert D; Cho JS; Wendler JP; Pattinson DJ; Barfod L; Douglas AD; Shea MW; Wright KE; de Cassan SC; Higgins MK; Draper SJ
    Front Immunol; 2019; 10():1254. PubMed ID: 31214195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype.
    Barrett JR; Pipini D; Wright ND; Cooper AJR; Gorini G; Quinkert D; Lias AM; Davies H; Rigby CA; Aleshnick M; Williams BG; Bradshaw WJ; Paterson NG; Martinson T; Kirtley P; Picard L; Wiggins CD; Donnellan FR; King LDW; Wang LT; Popplewell JF; Silk SE; de Ruiter Swain J; Skinner K; Kotraiah V; Noe AR; MacGill RS; King CR; Birkett AJ; Soisson LA; Minassian AM; Lauffenburger DA; Miura K; Long CA; Wilder BK; Koekemoer L; Tan J; Nielsen CM; McHugh K; Draper SJ
    Cell; 2024 Sep; 187(18):4964-4980.e21. PubMed ID: 39059380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex.
    Williams BG; King LDW; Pulido D; Quinkert D; Lias AM; Silk SE; Ragotte RJ; Davies H; Barrett JR; McHugh K; Rigby CA; Alanine DGW; Barfod L; Shea MW; Cowley LA; Dabbs RA; Pattinson DJ; Douglas AD; Lyth OR; Illingworth JJ; Jin J; Carnrot C; Kotraiah V; Christen JM; Noe AR; MacGill RS; King CR; Birkett AJ; Soisson LA; Skinner K; Miura K; Long CA; Higgins MK; Draper SJ
    Nat Commun; 2024 Jun; 15(1):4857. PubMed ID: 38849365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmodium falciparum Cysteine-Rich Protective Antigen (CyRPA) Elicits Detectable Levels of Invasion-Inhibitory Antibodies during Natural Infection in Humans.
    Mian SY; Somanathan A; Chaddha K; Pandey AK; Singh H; Krishna S; Chaturvedi N; Uchoi S; Shukla MM; Bharti PK; Singh N; Chauhan VS; Gaur D
    Infect Immun; 2022 Jan; 90(1):e0037721. PubMed ID: 34694918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A malaria vaccine candidate based on an epitope of the Plasmodium falciparum RH5 protein.
    Ord RL; Caldeira JC; Rodriguez M; Noe A; Chackerian B; Peabody DS; Gutierrez G; Lobo CA
    Malar J; 2014 Aug; 13():326. PubMed ID: 25135070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing Antibodies.
    Alanine DGW; Quinkert D; Kumarasingha R; Mehmood S; Donnellan FR; Minkah NK; Dadonaite B; Diouf A; Galaway F; Silk SE; Jamwal A; Marshall JM; Miura K; Foquet L; Elias SC; Labbé GM; Douglas AD; Jin J; Payne RO; Illingworth JJ; Pattinson DJ; Pulido D; Williams BG; de Jongh WA; Wright GJ; Kappe SHI; Robinson CV; Long CA; Crabb BS; Gilson PR; Higgins MK; Draper SJ
    Cell; 2019 Jun; 178(1):216-228.e21. PubMed ID: 31204103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APC-Targeted DNA Vaccination Against Reticulocyte-Binding Protein Homolog 5 Induces
    Bjerkan L; Visweswaran GRR; Gudjonsson A; Labbé GM; Quinkert D; Pattinson DJ; Spång HCL; Draper SJ; Bogen B; Braathen R
    Front Immunol; 2021; 12():720550. PubMed ID: 34733274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions.
    Payne RO; Silk SE; Elias SC; Miura K; Diouf A; Galaway F; de Graaf H; Brendish NJ; Poulton ID; Griffiths OJ; Edwards NJ; Jin J; Labbé GM; Alanine DG; Siani L; Di Marco S; Roberts R; Green N; Berrie E; Ishizuka AS; Nielsen CM; Bardelli M; Partey FD; Ofori MF; Barfod L; Wambua J; Murungi LM; Osier FH; Biswas S; McCarthy JS; Minassian AM; Ashfield R; Viebig NK; Nugent FL; Douglas AD; Vekemans J; Wright GJ; Faust SN; Hill AV; Long CA; Lawrie AM; Draper SJ
    JCI Insight; 2017 Nov; 2(21):. PubMed ID: 29093263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodies.
    King LDW; Pulido D; Barrett JR; Davies H; Quinkert D; Lias AM; Silk SE; Pattinson DJ; Diouf A; Williams BG; McHugh K; Rodrigues A; Rigby CA; Strazza V; Suurbaar J; Rees-Spear C; Dabbs RA; Ishizuka AS; Zhou Y; Gupta G; Jin J; Li Y; Carnrot C; Minassian AM; Campeotto I; Fleishman SJ; Noe AR; MacGill RS; King CR; Birkett AJ; Soisson LA; Long CA; Miura K; Ashfield R; Skinner K; Howarth MR; Biswas S; Draper SJ
    Cell Rep Med; 2024 Jul; 5(7):101654. PubMed ID: 39019011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and Immune Assessment of T Cell Epitopes in Five
    Kotraiah V; Phares TW; Terry FE; Hindocha P; Silk SE; Nielsen CM; Moise L; Tucker KD; Ashfield R; Martin WD; De Groot AS; Draper SJ; Gutierrez GM; Noe AR
    Front Immunol; 2021; 12():690348. PubMed ID: 34305923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin G subclass and antibody avidity responses in Malian children immunized with Plasmodium falciparum apical membrane antigen 1 vaccine candidate FMP2.1/AS02
    Berry AA; Gottlieb ER; Kouriba B; Diarra I; Thera MA; Dutta S; Coulibaly D; Ouattara A; Niangaly A; Kone AK; Traore K; Tolo Y; Mishcherkin V; Soisson L; Diggs CL; Blackwelder WC; Laurens MB; Sztein MB; Doumbo OK; Plowe CV; Lyke KE
    Malar J; 2019 Jan; 18(1):13. PubMed ID: 30658710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing neutralization of Plasmodium falciparum using a novel monoclonal antibody against the rhoptry-associated membrane antigen.
    Knudsen AS; Walker MR; Agullet JP; Björnsson KH; Bassi MR; Barfod L
    Sci Rep; 2022 Feb; 12(1):3040. PubMed ID: 35197516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterially expressed full-length recombinant Plasmodium falciparum RH5 protein binds erythrocytes and elicits potent strain-transcending parasite-neutralizing antibodies.
    Reddy KS; Pandey AK; Singh H; Sahar T; Emmanuel A; Chitnis CE; Chauhan VS; Gaur D
    Infect Immun; 2014 Jan; 82(1):152-64. PubMed ID: 24126527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naturally acquired antibodies specific for Plasmodium falciparum reticulocyte-binding protein homologue 5 inhibit parasite growth and predict protection from malaria.
    Tran TM; Ongoiba A; Coursen J; Crosnier C; Diouf A; Huang CY; Li S; Doumbo S; Doumtabe D; Kone Y; Bathily A; Dia S; Niangaly M; Dara C; Sangala J; Miller LH; Doumbo OK; Kayentao K; Long CA; Miura K; Wright GJ; Traore B; Crompton PD
    J Infect Dis; 2014 Mar; 209(5):789-98. PubMed ID: 24133188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of biological activity of human anti-apical membrane antigen-1 antibodies induced by natural infection and vaccination.
    Miura K; Zhou H; Moretz SE; Diouf A; Thera MA; Dolo A; Doumbo O; Malkin E; Diemert D; Miller LH; Mullen GE; Long CA
    J Immunol; 2008 Dec; 181(12):8776-83. PubMed ID: 19050299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strain-Dependent Inhibition of Erythrocyte Invasion by Monoclonal Antibodies Against
    Knudsen AS; Björnsson KH; Bassi MR; Walker MR; Kok A; Cristinoi B; Jensen AR; Barfod L
    Front Immunol; 2021; 12():716305. PubMed ID: 34447381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural and Vaccine-Induced Acquisition of Cross-Reactive IgG-Inhibiting ICAM-1-Specific Binding of a Plasmodium falciparum PfEMP1 Subtype Associated Specifically with Cerebral Malaria.
    Olsen RW; Ecklu-Mensah G; Bengtsson A; Ofori MF; Lusingu JPA; Castberg FC; Hviid L; Adams Y; Jensen ATR
    Infect Immun; 2018 Apr; 86(4):. PubMed ID: 29426042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bliss' and Loewe's additive and synergistic effects in Plasmodium falciparum growth inhibition by AMA1-RON2L, RH5, RIPR and CyRPA antibody combinations.
    Azasi Y; Gallagher SK; Diouf A; Dabbs RA; Jin J; Mian SY; Narum DL; Long CA; Gaur D; Draper SJ; Fay MP; Miller LH; Miura K
    Sci Rep; 2020 Jul; 10(1):11802. PubMed ID: 32678144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.